CVRx, Inc. (CVRX) symbol metrics page

CVRx Inc. (CVRX) NASDAQ

$13.93 (0.48) (-3.30%)

Market Cap: $310.97M

As of 04/25/24 11:12 AM EDT. Market open.

(CVRX)

CVRx Inc. (CVRX)
NASDAQ

$13.93
(0.48) (-3.30%)

Market Cap: $310.97M

As of 04/25/24 11:12 AM EDT. Market open.

Add to Portfolio

cvrx is a private company located in minneapolis, minnesota. the company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. the barostim neo™ uses cvrx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. the barostim neo can be adjusted to meet each patient’s ... read more

COMPANY PROFILE

Sector

Manufacturing

Industry

Surgical and Medical Instrument Manufacturing

URL

Address

.

Sector

Manufacturing

Industry

Surgical and Medical Instrument Manufacturing

Full Time Employees

184

URL

Address

.

PRICE CHART FOR CVRX INC

1w

1m

3m

6m

YTD

1y

5y

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

$14.12

Previous Close

$14.40

Days Range

$14.03 - $14.57

52 week range

$9.27 - $33.14

Volume

29,539

Avg. Volume (30 days)

119,127

Market Cap

$310.97M

Dividend Yield

-

P/E

(7.55)

Shares Outstanding

21,595,464

Open

$14.12

Previous Close

$14.40

Days Range

$14.03 - $14.57

52 week range

$9.27 - $33.14

Volume

29,539

Avg. Volume (30 days)

119,127

Market Cap

$310.97M

Dividend Yield

-

P/E

(7.55)

Shares Outstanding

21,595,464

FINANCIAL STATEMENTS FOR CVRX INC

LOADING...

Open in:

Open in:

INSIDER TRANSACTIONS FOR CVRX INC

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Palmer Craig E.	SVP, U.S. SALES	Mar 25, 2024	Option Exercise	$0.24	934	221	1,229	Mar 27, 2024, 04:56 PM
JOHNSON & JOHNSON	10% Owner	Feb 29, 2024	Option Exercise	$0.72	3,855	2,792	4,103,430	Mar 06, 2024, 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16, 2024	Sale	$25.81	3,725	96,142	4,099,575	Mar 06, 2024, 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16, 2024	Option Exercise	$0.16	607,725	96,021	4,103,300	Mar 06, 2024, 03:42 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Feb 20, 2024	Option Exercise	$5.14	5,000	25,705	5,000	Feb 22, 2024, 06:05 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Feb 20, 2024	Sale	$21.91	2,545	55,748	2,455	Feb 22, 2024, 06:05 PM
Yared Nadim	CHIEF EXECUTIVE OFFICER	Jan 29, 2024	Option Exercise	$0.24	6,000	1,422	26,255	Jan 31, 2024, 04:26 PM
SLATTERY JOSEPH P	Director	Dec 28, 2023	Option Exercise	$0.50	1,950	984	22,145	Jan 02, 2024, 04:57 PM
Behbahani Ali	Director	Dec 14, 2023	Option Exercise	$0.24	316	75	316	Dec 18, 2023, 04:40 PM
Galle Liz	VP OF GLOBAL CLINICAL RESEARCH	Oct 16, 2023	Option Exercise	$0.24	778	184	778	Oct 18, 2023, 04:51 PM
OASHEIM JARED	CHIEF FINANCIAL OFFICER	Sep 18, 2023	Option Exercise	$3.62	5,862	21,225	15,447	Sep 20, 2023, 04:04 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Aug 03, 2023	Sale	$18.55	628	11,652	0	Aug 07, 2023, 04:58 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Jul 31, 2023	Option Exercise	$5.14	3,750	19,279	3,750	Aug 02, 2023, 06:29 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Jul 31, 2023	Sale	$17.49	1,122	19,629	2,628	Aug 02, 2023, 06:29 PM
Palmer Craig E.	SVP, U.S. SALES	May 16, 2023	Option Exercise	$0.24	295	70	295	May 18, 2023, 04:51 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 28, 2022	Option Exercise	$5.14	9,000	46,269	9,000	Nov 30, 2022, 05:55 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 28, 2022	Sale	$11.94	4,600	54,931	5,000	Nov 30, 2022, 05:55 PM
OASHEIM JARED	CHIEF FINANCIAL OFFICER	Jun 02, 2022	Option Exercise	$0.24	9,585	2,272	9,585	Jun 06, 2022, 04:18 PM
Nielsen Kirk G.	Director	May 24, 2022	Buy	$5.05	8,070	40,752	1,711,355	May 26, 2022, 06:13 PM
Nielsen Kirk G.	Director	May 19, 2022	Buy	$5.04	10,976	55,297	1,685,466	May 23, 2022, 07:56 PM
Nielsen Kirk G.	Director	May 23, 2022	Buy	$5.04	4,432	22,336	1,703,285	May 23, 2022, 07:56 PM
Nielsen Kirk G.	Director	May 20, 2022	Buy	$5.04	13,387	67,409	1,698,853	May 23, 2022, 07:56 PM
Nielsen Kirk G.	Director	May 02, 2022	Buy	$5.97	41,988	250,673	1,612,186	May 02, 2022, 05:34 PM
Nielsen Kirk G.	Director	Apr 28, 2022	Buy	$5.97	100	597	1,570,198	May 02, 2022, 05:34 PM
Yared Nadim	CHIEF EXECUTIVE OFFICER	Apr 25, 2022	Option Exercise	$0.24	6,059	1,436	27,335	Apr 27, 2022, 04:24 PM
BRINTNALL JOHN	CHIEF STRATEGY OFFICER AND SEC	Apr 22, 2022	Option Exercise	$0.24	11,451	2,714	21,901	Apr 26, 2022, 04:17 PM
Jain Mudit K.	Director	Feb 28, 2022	Buy	$9.03	600	5,420	3,400	Mar 02, 2022, 04:08 PM
Nielsen Kirk G.	Director	Feb 24, 2022	Buy	$8.24	3,400	28,010	1,570,098	Feb 28, 2022, 05:17 PM
Nielsen Kirk G.	Director	Feb 23, 2022	Buy	$8.04	38,200	307,143	1,566,698	Feb 23, 2022, 05:36 PM
Nielsen Kirk G.	Director	Feb 22, 2022	Buy	$7.94	40,008	317,660	1,528,498	Feb 23, 2022, 05:36 PM
Nielsen Kirk G.	Director	Feb 18, 2022	Buy	$7.92	26,659	211,227	1,488,490	Feb 23, 2022, 05:36 PM
BRUHN-DING DEAN	VP of Reg. Affairs and QA	Feb 08, 2022	Option Exercise	$0.24	35,000	8,295	54,648	Feb 10, 2022, 05:21 PM
Yared Nadim	Chief Executive Officer	Feb 03, 2022	Option Exercise	$0.24	18,690	4,430	21,276	Feb 07, 2022, 04:30 PM
SLATTERY JOSEPH P	Director	Jan 13, 2022	Option Exercise	$0.28	11,640	3,313	20,195	Jan 18, 2022, 05:47 PM
BRINTNALL JOHN	Chief Strategy Officer and Sec	Dec 30, 2021	Option Exercise	$0.24	2,550	604	10,450	Jan 03, 2022, 04:25 PM
Yared Nadim	Chief Executive Officer	Dec 28, 2021	Option Exercise	$0.24	2,080	493	13,086	Dec 30, 2021, 04:13 PM
SLATTERY JOSEPH P	Director	Nov 30, 2021	Option Exercise	$0.24	3,000	720	8,555	Dec 02, 2021, 04:06 PM
BRUHN-DING DEAN	VP of Reg. Affairs and QA	Nov 24, 2021	Option Exercise	$0.24	14,000	3,360	19,648	Nov 29, 2021, 04:20 PM
Yared Nadim	Chief Executive Officer	Nov 22, 2021	Option Exercise	$0.24	11,006	2,641	11,006	Nov 24, 2021, 04:19 PM
Jain Mudit K.	Director	Nov 18, 2021	Buy	$14.63	875	12,804	2,500	Nov 19, 2021, 05:54 PM
Jain Mudit K.	Director	Nov 19, 2021	Buy	$13.69	300	4,106	2,800	Nov 19, 2021, 05:54 PM
Jain Mudit K.	Director	Aug 12, 2021	Buy	$19.72	625	12,328	1,625	Aug 16, 2021, 04:35 PM
NEA PARTNERS 10 L P	10% Owner	Jul 02, 2021	Buy	$18.00	24,750	445,500	173,388	Jul 07, 2021, 04:47 PM
NEA PARTNERS 10 L P	10% Owner	Jul 02, 2021	Buy	$18.00	225,500	4,059,000	2,026,083	Jul 07, 2021, 04:47 PM
NEW ENTERPRISE ASSOCIATES 10 L P	10% Owner	Jul 02, 2021	Buy	$18.00	225,500	4,059,000	2,026,083	Jul 07, 2021, 04:47 PM
GLAXOSMITHKLINE PLC	10% Owner	Jul 02, 2021	Buy	$18.00	275,000	4,950,000	1,007,583	Jul 06, 2021, 04:38 PM
NEHRA JOHN M	Director	Jul 02, 2021	Buy	$18.00	27,777	499,986	28,266	Jul 02, 2021, 05:04 PM
NEHRA JOHN M	Director	Jul 01, 2021	Buy	$25.80	50	1,290	100	Jul 02, 2021, 05:04 PM
NEHRA JOHN M	Director	Jun 30, 2021	Buy	$27.43	50	1,371	50	Jul 02, 2021, 05:04 PM
Jain Mudit K.	Director	Jul 02, 2021	Buy	$18.00	222,222	3,999,996	933,383	Jul 02, 2021, 05:04 PM
Jain Mudit K.	Director	Jul 01, 2021	Buy	$25.10	1,000	25,100	1,000	Jul 02, 2021, 05:04 PM
SLATTERY JOSEPH P	Director	Jul 02, 2021	Option Exercise	$18.00	5,555	99,990	5,555	Jul 02, 2021, 05:03 PM
Pardo Geoffrey B	Director	Jul 02, 2021	Buy	$18.00	275,000	4,950,000	1,829,022	Jul 02, 2021, 05:03 PM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Palmer Craig E.	SVP, U.S. SALES	03/25/2024	221
JOHNSON & JOHNSON	10% Owner	02/29/2024	2,792
JOHNSON & JOHNSON	10% Owner	02/16/2024	96,142
JOHNSON & JOHNSON	10% Owner	02/16/2024	96,021
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	02/20/2024	25,705
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	02/20/2024	55,748
Yared Nadim	CHIEF EXECUTIVE OFFICER	01/29/2024	1,422
SLATTERY JOSEPH P	Director	12/28/2023	984
Behbahani Ali	Director	12/14/2023	75
Galle Liz	VP OF GLOBAL CLINICAL RESEARCH	10/16/2023	184
OASHEIM JARED	CHIEF FINANCIAL OFFICER	09/18/2023	21,225
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	08/03/2023	11,652
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	07/31/2023	19,279
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	07/31/2023	19,629
Palmer Craig E.	SVP, U.S. SALES	05/16/2023	70
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	11/28/2022	46,269
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	11/28/2022	54,931
OASHEIM JARED	CHIEF FINANCIAL OFFICER	06/02/2022	2,272
Nielsen Kirk G.	Director	05/24/2022	40,752
Nielsen Kirk G.	Director	05/19/2022	55,297
Nielsen Kirk G.	Director	05/23/2022	22,336
Nielsen Kirk G.	Director	05/20/2022	67,409
Nielsen Kirk G.	Director	05/02/2022	250,673
Nielsen Kirk G.	Director	04/28/2022	597
Yared Nadim	CHIEF EXECUTIVE OFFICER	04/25/2022	1,436
BRINTNALL JOHN	CHIEF STRATEGY OFFICER AND SEC	04/22/2022	2,714
Jain Mudit K.	Director	02/28/2022	5,420
Nielsen Kirk G.	Director	02/24/2022	28,010
Nielsen Kirk G.	Director	02/23/2022	307,143
Nielsen Kirk G.	Director	02/22/2022	317,660
Nielsen Kirk G.	Director	02/18/2022	211,227
BRUHN-DING DEAN	VP of Reg. Affairs and QA	02/08/2022	8,295
Yared Nadim	Chief Executive Officer	02/03/2022	4,430
SLATTERY JOSEPH P	Director	01/13/2022	3,313
BRINTNALL JOHN	Chief Strategy Officer and Sec	12/30/2021	604
Yared Nadim	Chief Executive Officer	12/28/2021	493
SLATTERY JOSEPH P	Director	11/30/2021	720
BRUHN-DING DEAN	VP of Reg. Affairs and QA	11/24/2021	3,360
Yared Nadim	Chief Executive Officer	11/22/2021	2,641
Jain Mudit K.	Director	11/18/2021	12,804
Jain Mudit K.	Director	11/19/2021	4,106
Jain Mudit K.	Director	08/12/2021	12,328
NEA PARTNERS 10 L P	10% Owner	07/02/2021	445,500
NEA PARTNERS 10 L P	10% Owner	07/02/2021	4,059,000
NEW ENTERPRISE ASSOCIATES 10 L P	10% Owner	07/02/2021	4,059,000
GLAXOSMITHKLINE PLC	10% Owner	07/02/2021	4,950,000
NEHRA JOHN M	Director	07/02/2021	499,986
NEHRA JOHN M	Director	07/01/2021	1,290
NEHRA JOHN M	Director	06/30/2021	1,371
Jain Mudit K.	Director	07/02/2021	3,999,996
Jain Mudit K.	Director	07/01/2021	25,100
SLATTERY JOSEPH P	Director	07/02/2021	99,990
Pardo Geoffrey B	Director	07/02/2021	4,950,000

Load More Insider Transactions

FUNDS WITH A POSITION IN CVRX INC

Fund	# Shares Owned	% of Portfolio	% Change	Investing Style
BLACKROCK INC.	803,434	0.00064%	9.92%	Other
BALYASNY ASSET MANAGEMENT L.P.	407,008	0.02%	-39.7%	Event Driven
GEODE CAPITAL MANAGEMENT, LLC	249,543	0.00082%	5.72%	Other
ROYCE & ASSOCIATES LP	114,000	0.03%	61.9%	Value
RENAISSANCE TECHNOLOGIES LLC	55,900	0.00272%	-14.92%	Other
D. E. SHAW & CO., INC.	40,273	0.00111%	107.26%	Other
AQR CAPITAL MANAGEMENT LLC	7,191	0.00043%	New	Other

CHANGE IN SHARES OUTSTANDING FOR CVRX INC

STOCK BUYBACKS FOR CVRX INC

Period of Report

Previous Period

% Change in Shares

10-K/10-Q Filings

Quarter

12/31/2023

09/30/2023

0.13%

1Q

12/31/2023

06/30/2023

0.56%

2Q

12/31/2023

03/31/2023

0.65%

3Q

12/31/2023

12/31/2022

1.13%

4Q

12/31/2023

09/30/2022

1.22%

5Q

12/31/2023

06/30/2022

1.57%

6Q

12/31/2023

03/31/2022

1.83%

7Q

12/31/2023

09/30/2021

3.48%

9Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period

% Change in Shares

Quarter

09/30/2023

0.13%

1Q

06/30/2023

0.56%

2Q

03/31/2023

0.65%

3Q

12/31/2022

1.13%

4Q

09/30/2022

1.22%

5Q

06/30/2022

1.57%

6Q

03/31/2022

1.83%

7Q

09/30/2021

3.48%

9Q

BUYBACK ANNOUNCEMENT(S) FOR CVRX INC

Active Completed

LOADING...